Can IVIG intervene in AD? Insights from animal experiments——A systematic review and synthesis without meta-analysis
Abstract
Intravenous immunoglobulin (IVIG)'s efficacy on Alzheimer's disease (AD) remains inconclusive and appears closely related to specific functional properties.
Fields of Study & Subjects
Alzheimer's disease research and treatments
Dementia and Cognitive Impairment Research
Monoclonal and Polyclonal Antibodies Research
Publication details
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Preprint